Tempus AI's diagnostics arm is surging in 2025 as precision oncology testing, MRD adoption, AI-driven genomic tools and the Ambry Genetics acquisition expand capabilities.

Late in 2025, we covered the development of an AI system called Evo that was trained on massive numbers of bacterial genomes. So many that, when prompted with sequences from a cluster of related genes ...

When the performance of AI models was assessed within stratified patient subgroups, such as only high-grade breast cancers or ...

Morgan Stanley Technology, Media & Telecom Conference 2026 March 3, 2026 12:15 PM ESTCompany ParticipantsEric Lefkofsky ...

A practical MCP security benchmark for 2026: scoring model, risk map, and a 90-day hardening plan to prevent prompt injection, secret leakage, and permission abuse.

This study presents valuable findings implicating nuclear export in the regulation of protein condensate behaviour and TDP-43 phase behaviour, suggesting a link to pathogenic aggregation in ALS/FTD.

GPT-5.4 is also more reliable, producing 18% fewer errors and 33% fewer false claims than GPT-5.2, according to OpenAI.

Veterinary focused AI scribe VetNotes. During Mitch Sigley’s childhood, he noticed that his parents—both veterinarians—would frequently arrive home late because they had to ...

In a French criminal trial, conventional DNA analysis couldn’t distinguish between twin brothers, but emerging scientific methods could help in such cases.

The Companion Diagnostics Market has emerged as a critical pillar of modern precision medicine, enabling healthcare providers to match patients with therapies that are most likely to deliver effective ...

This study presents a valuable finding on the mutational order for common alterations in colorectal cancer. The evidence of in vitro growth assays comparing mutations is solid, although inclusion of ...

Erasca (NASDAQ:ERAS) executives outlined the company’s strategy to target RAS-driven cancers and previewed upcoming clinical ...